Chemotherapy-Induced Nausea and Vomiting (CINV) Market Expected to Reach $2,659 Million, Globally, by 2022
The Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market was valued at $1,663 million in 2015, and is estimated to reach $2,659 million by 2022, registering a CAGR of 7.1% during the forecast period 2016-2022.
View full press release